47
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Upregulation of Cullin 4B Promotes Gastric Cancer and Predicts Poor Prognosis

, , &
Pages 1235-1243 | Published online: 11 Feb 2020

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
  • Wu D, Zhao L, Liu Y, et al. The superiority of 256-slice spiral computed tomography angiography for preoperative evaluation of surrounding arteries in patients with gastric cancer. Onco Targets Ther. 2017;10:927–933. doi:10.2147/OTT28243128
  • Chen PF, Wang F, Nie JY, et al. Co-expression network analysis identified CDH11 in association with progression and prognosis in gastric cancer. Onco Targets Ther. 2018;11:6425–6436. doi:10.2147/OTT.S17651130323620
  • Sheng S, Chen Y, Li C. Outcomes of laparoscopic total gastrectomy for elderly gastric cancer patients. J Cancer. 2018;9(23):4398–4403. doi:10.7150/jca.2685830519345
  • Li B, Zhang S, Shen H, Li C. MicroRNA-144-3p suppresses gastric cancer progression by inhibiting epithelial-to-mesenchymal transition through targeting PBX3. Biochem Biophys Res Commun. 2017;484(2):241–247. doi:10.1016/j.bbrc.2017.01.08428111340
  • Zhang BG, Hu L, Zang MD, et al. Helicobacter pylori CagA induces tumor suppressor gene hypermethylation by upregulating DNMT1 via AKT-NFkappaB pathway in gastric cancer development. Oncotarget. 2016;7(9):9788–9800. doi:10.18632/oncotarget.712526848521
  • Ren J, Niu G, Wang X, Song T, Hu Z, Ke C. Overexpression of FNDC1 in gastric cancer and its prognostic significance. J Cancer. 2018;9(24):4586–4595. doi:10.7150/jca.2767230588242
  • Van Cutsem E, Sagaert X, Topal B, Haustermans K, Prenen H. Gastric cancer. Lancet. 2016;388(10060):2654–2664. doi:10.1016/S0140-6736(16)30354-327156933
  • Jia S, Kobayashi R, Grewal SI. Ubiquitin ligase component Cul4 associates with Clr4 histone methyltransferase to assemble heterochromatin. Nat Cell Biol. 2005;7(10):1007–1013. doi:10.1038/ncb130016127433
  • Jackson S, Xiong Y. CRL4s: the CUL4-RING E3 ubiquitin ligases. Trends Biochem Sci. 2009;34(11):562–570. doi:10.1016/j.tibs.2009.07.00219818632
  • Higa LA, Yang X, Zheng J, et al. Involvement of CUL4 ubiquitin E3 ligases in regulating CDK inhibitors Dacapo/p27Kip1 and cyclin E degradation. Cell Cycle. 2006;5(1):71–77. doi:10.4161/cc.5.1.226616322693
  • Lee J, Zhou P. Pathogenic role of the CRL4 ubiquitin ligase in human disease. Front Oncol. 2012;2:21. doi:10.3389/fonc.2012.0002122649780
  • Zou Y, Liu Q, Chen B, et al. Mutation in CUL4B, which encodes a member of cullin-RING ubiquitin ligase complex, causes X-linked mental retardation. Am J Hum Genet. 2007;80(3):561–566. doi:10.1086/51248917273978
  • Hu H, Yang Y, Ji Q, et al. CRL4B catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to promote tumorigenesis. Cancer Cell. 2012;22(6):781–795. doi:10.1016/j.ccr.2012.10.02423238014
  • Wang X, Chen Z. Knockdown of CUL4B suppresses the proliferation and invasion in non-small cell lung cancer cells. Oncol Res. 2016;24(4):271–277. doi:10.3727/096504016X1466699034747327656838
  • Jiang T, Tang HM, Wu ZH, et al. Cullin 4B is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Med Oncol. 2013;30(2):534. doi:10.1007/s12032-013-0534-723649548
  • Schindl M, Gnant M, Schoppmann SF, Horvat R, Birner P. Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer. Anticancer Res. 2007;27(2):949–952.17465225
  • Chen Z, Shen BL, Fu QG, et al. CUL4B promotes proliferation and inhibits apoptosis of human osteosarcoma cells. Oncol Rep. 2014;32(5):2047–2053. doi:10.3892/or.2014.346525189186
  • Zhang B, Zhang Y, Zhang X, Lv Y. Suspension state promotes extravasation of breast tumor cells by increasing integrin β1 expression. Biocell. 2018;42(1):17–24. doi:10.32604/biocell.2018.06115
  • Yang Y, Liu R, Qiu R, et al. CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing. Oncogene. 2015;34(1):104–118. doi:10.1038/onc.2013.52224292684
  • Yuan J, Han B, Hu H, et al. CUL4B activates Wnt/beta-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists. J Pathol. 2015;235(5):784–795. doi:10.1002/path.449225430888